Regional differences in the prevalence of the metabolic syndrome in primary care practices in Germany;Regional unterschiedliche prävalenz des metabolischen syndroms: Daten zur primärärztlichen versorgung in Deutschland

Deutsches Arzteblatt

Volumn 105, Issue 12, 2008, Pages 207-213

  Moebus, Susanne ^a   Hanisch, Jens ^a   Bramlage, Peter ^b   Lösch, Christian ^a   Hauner, Hans ^c   Wasem, Jürgen ^d   Jöckel, Karl Heinz ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Cardiovascular risk factors; Diabetes mellitus; Germany; Metabolic syndrome; Prevalence; Primary care

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CLINICAL PRACTICE; DIABETES MELLITUS; FEMALE; GEOGRAPHIC DISTRIBUTION; GERMANY; GLUCOSE BLOOD LEVEL; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PREVALENCE; PRIMARY MEDICAL CARE; SEX DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

EID: 41749105335     PISSN: 00121207     EISSN: None     Source Type: Journal    
DOI: 10.3238/artzebl.2008.0207     Document Type: Article

References (25)

1. Tunstall-Pedoe H, Kuulasmaa K, Mahonen M, Tolonen H, Ruokokoski E, Amouyel P: Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease. Lancet 1999; 353: 1547-57.
2. Sans S, Kesteloot H, Kromhout D: The burden of cardiovascular diseases mortality in Europe. Task Force of the European Society of Cardiology on Cardiovascular Mortality and Morbidity Statistics in Europe. Eur Heart J 1997; 18: 1231-48; erratum Eur Heart J 1997; 18: 1231-48.
3. Willich SN: Regionale Unterschiede der Herz-Kreislauf-Mortalität in Deutschland. Dtsch Arztebl 1999; 96(8): A 483-8.
4. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA et al.: Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112: 2735-52.
5. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-97.
6. Neuhauser HK, Ellert U: Prävalenz des metabolischen Syndroms in Deutschland: eine Sensitivitätsanalyse. gms german medical science 2005; Meeting abstract, http://www.egms.de/en/meetings/gmds2005/05gmds183.shtml.
7. Moebus S, Hanisch J, Aidelsburger P, Bramlage P, Wasem J, Jöckel KH; Impact of 4 different definitions used for the assessment of the prevalence of the Metabolic Syndrome in primary healthcare: The German Metabolic and Cardiovascular Risk Project (GEMCAS). Cardiovascular Diabetology 2007; 6: 22.
8. Moebus S, Hanisch J, Neuhaeuser M, Aidelsburger P, Wasem J, Joeckel K-H: Assessing the prevalence of the Metabolic Syndrome according to NCEP ATP III in Germany: feasibility and duality aspects of a two step approach in 1550 randomly selected primary health care practices. GMS Ger Med Sci 2006; 4:Doc07, http://www.egms.de/en/gms/2006-4/000036.shtml.
9. Deutsche Arbeitsgemeinschaft für Epidemiologic Leitlinien und Empfehlungen zur Sicherung von Guter Epidemiologischer Praxis (GEP). http://www.gesundheitsforschung-bmbf.de/_media/Empfehlungen_GEP.pdf.2004.
10. Kohler E, Ziese T: Telefonischer Gesundheitssurvey des Robert Koch-Instituts zu chronischen Krankheiten und ihren Bedingungen. Berlin: Robert Koch-Institut 2004.
11. Hauner H, Hanisch J, Bramlage P, Steinhagen-Thiessen E, Schunkert H, Jöckel KH, Wasem J, Moebus S; Prevalence of undiagnosed type-2-diabetes mellitus and impaired fasting glucose in german primary care: data from the German Metabolic and Cardiovascular Risk Project (GEMCAS). Experimental and Clinical Endocrinology & Diabetes 2008; 1: 18-25.
12. Grundy S, Brewer H, Cleeman J, Smith S, Lenfant C: Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association. Circulation 2004; 109: 433-438.
13. Statistisches Bundesamt. Statistisches Jahrbuch für die Bundesrepublik Deutschland 2006. Statistisches Bundesamt Wiesbaden 2006. https://www-ec.destatis.de.
14. Adams KF, Schatzkin A, Harris TB, Kipnis V, Mouw T, Ballard-Barbash R et al.: Overweight, obesity and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med 2006; 355: 763-778.
15. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R: Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360: 1903-13.
16. Jee SH, Sull JW, Park J, Lee SY, Ohrr H, Guallar E et al.: Body-mass index and mortality in korean men and women. N Engl J Med 2006; 355: 779-87.
17. Hauner H: Gesundheitsrisiken von Übergewicht und Gewichtszunahme. Dtsch Arztebl 1996; 93(51-52): A-3405-9.
18. Laaksonen DE, Lakka HM, Niskanen LK, Kaplan GA, Salonen JT, Lakka TA: Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study. Am J Epidemiol 2002; 156: 1070-1077.
19. Lorenzo C, Okoloise M, Williams K, Stern MP, Haffner SM: The metabolic syndrome as predictor of type 2 diabetes: the San Antonio Heart Study. Diabetes Care 2003; 26: 3153-59.
20. Moebus S, Stang A: Das metabolische Syndrom - ein umstrittenes diagnostisches Konzept. Herz 2007; 32: 529-40.
21. Keil U, Liese AD, Hense HW et al.: Classical risk factors and their impact on incident non-fatal and fatal myocardial infarction and all-cause mortality in southern Germany. Results from the MONICA Augsburg cohort study 1984-1992. Monitoring trends and determinants in cardiovascular diseases. Eur Heart J 1998; 19: 1197-207.
22. John U, Greiner B, Hensel E, Lüdermann J, Piek M, Sauer S et al.: Study of health in pomerania (SHIP): a health examination survey in an east German region: objectives and design. Soz Präventivmed 2001; 46: 186-94.
23. Greiser K, Kluttig A, Schumann B, Kors J, Swenne C, Kuss O et al.: Cardiovascular disease, risk factors and heart rate variability in the elderly general population: Design and objectives of the CARdiovascular disease, Living and Aging in Halle (CARLA) Study. BMC Cardiovascular Disorders 2005; 5: 33.
24. Schmermund A, Möhlenkamp S, Stang A, Grönemeyer D, Seibel R, Hirche H et al.: Assessment of clinically silent atherosclerotic disease and established and novel risk factors for predicting myocardial infarction and cardiac death in healthy middle-aged subjects: rationale and design of the Heinz Nixdorf Recall Study. Risk factors, evaluation of coronary calcium and lifestyle. Am Heart J 2002; 144: 212-8.
25. Alberti KG, Zimmet P, Shaw J, IDF Epidemiology Task Force Consensus Group: The metabolic syndrome - a new worldwide definition. Lancet 2005; 366: 1059-62.